Axxcess Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1M Buy
87,916
+15,478
+21% +$3.33M 0.35% 60
2026
Q1
$15.8M Sell
72,438
-2,786
-4% -$618K 0.5% 46
2025
Q4
$17.2M Buy
75,224
+518
+0.7% +$118K 0.3% 68
2025
Q3
$17.3M Buy
74,706
+3,597
+5% +$732K 0.37% 55
2025
Q2
$13.2M Buy
71,109
+2,122
+3% +$394K 0.31% 68
2025
Q1
$14.5M Buy
68,987
+669
+1% +$130K 0.38% 59
2024
Q4
$12.1M Buy
68,318
+3,570
+6% +$656K 0.29% 66
2024
Q3
$12.8M Sell
64,748
-2,749
-4% -$513K 0.31% 62
2024
Q2
$11.6M Sell
67,497
-1,884
-3% -$312K 0.31% 62
2024
Q1
$12.6M Sell
69,381
-762
-1% -$131K 0.35% 58
2023
Q4
$10.9M Buy
70,143
+5,717
+9% +$833K 0.32% 68
2023
Q3
$9.6M Buy
64,426
+31,054
+93% +$4.56M 0.33% 66
2023
Q2
$4.5M Sell
33,372
-11,067
-25% -$1.62M 0.33% 72
2023
Q1
$7.08M Buy
44,439
+2,363
+6% +$361K 0.54% 39
2022
Q4
$6.8M Buy
42,076
+9,662
+30% +$1.48M 0.56% 38
2022
Q3
$4.35M Sell
32,414
-2,635
-8% -$378K 0.41% 51
2022
Q2
$5.37M Sell
35,049
-5,351
-13% -$818K 0.49% 42
2022
Q1
$6.55M Buy
40,400
+5,283
+15% +$767K 0.51% 39
2021
Q4
$4.76M Buy
+35,117
New +$4.15M 0.35% 57

Other funds holding ABBV

Axxcess Wealth Management's ABBV Position: Q2 2026 in Review

Axxcess Wealth Management increased its AbbVie (ABBV) stake by 21% in Q2 2026, buying an estimated $3.33M and bringing the position to 87,916 shares worth $22.1M. The position accounts for 0.35% of the portfolio, ranked #60.

Axxcess Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Axxcess Wealth Management held 87,916 shares of AbbVie worth $22.1M as of Q2 2026.
  • Axxcess Wealth Management bought 15,478 AbbVie shares in Q2 2026, an estimated $3.33M.
  • AbbVie made up 0.35% of Axxcess Wealth Management's portfolio in Q2 2026, its #60 holding.
  • Axxcess Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Axxcess Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.